Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-08

Clinical Trial Update: Fr1da Insulin Intervention [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Fr1da insulin intervention sponsored by Technical University of Munich, with the study completed in Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Technical University of Munich | Conditions: Stage 1 Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED